Studies have shown that XIAP antisense nucleic acid and small molecule inhibitors of XIAP induce apoptosis and inhibit tumor growth in HCC cells [9], indicating that targeting inhibition of XIAP may be a new approach for HCC therapy [10]. This evidence concerns the gene XIAP and hepatocellular carcinoma.